• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The unstable atheroma.

作者信息

Lee R T, Libby P

机构信息

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1859-67. doi: 10.1161/01.atv.17.10.1859.

DOI:10.1161/01.atv.17.10.1859
PMID:9351346
Abstract
摘要

相似文献

1
The unstable atheroma.不稳定动脉粥样硬化斑块
Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1859-67. doi: 10.1161/01.atv.17.10.1859.
2
[Current medical treatment of atherosclerosis].
Rev Clin Esp. 1977 Dec 15;147(5):549-54.
3
Action of the urinary antisteroid substance in experimental atheromatosis.
Rev Roum Med. 1974;12(3):185-8.
4
Cholesterol and strokes. Cholesterol lowering is indicated for strokes due to carotid atheroma.胆固醇与中风。降低胆固醇适用于因颈动脉粥样硬化导致的中风。
BMJ. 2000 Feb 19;320(7233):459-60. doi: 10.1136/bmj.320.7233.459.
5
Assessing the value and affordability of cholesterol reduction in the managed care setting.评估在管理式医疗环境中降低胆固醇的价值和可承受性。
Am J Manag Care. 1998 Apr;4(4 Suppl):S226-33; quiz S234-5.
6
[Arteriosclerosis with special reference to anticholesteremic agents].
Naika. 1970 Jun;25(6):1082-6.
7
Systemic cause of unstable atherosclerotic plaques. Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque (ATROCAP) study group.
Lancet. 2000 Apr 15;355(9212):1362-3; author reply 1363-4.
8
[Treatment of arteriosclerosis by Atromid].
Rev Med Moyen Orient. 1967 Nov-Dec;24(6):504-11.
9
[Prescriptions for arteriosclerosis therapy].
Clin Ter. 1978 Mar 31;84(6):641-7.
10
[Pharmacologic therapy of arteriosclerosis: current possibilities].
Med Clin (Barc). 1984 Oct 6;83(10):431-2.

引用本文的文献

1
Sex differences in features of atherosclerotic plaques as revealed by various imaging techniques: historical review.各种成像技术揭示的动脉粥样硬化斑块特征中的性别差异：历史回顾
Front Physiol. 2025 May 26;16:1579885. doi: 10.3389/fphys.2025.1579885. eCollection 2025.
2
lncRNA CDKN2B-AS1 regulates collagen expression.长链非编码RNA CDKN2B-AS1调节胶原蛋白的表达。
Hum Genet. 2024 Jul;143(7):907-919. doi: 10.1007/s00439-024-02674-1. Epub 2024 Jun 4.
3
A parametric study of the effect of 3D plaque shape on local hemodynamics and implications for plaque instability.
三维斑块形态对局部血液动力学影响的参数研究及其对斑块不稳定性的意义。
Biomech Model Mechanobiol. 2024 Aug;23(4):1209-1227. doi: 10.1007/s10237-024-01834-6. Epub 2024 Mar 26.
4
Intravascular Imaging versus Physiological Assessment versus Biomechanics-Which Is a Better Guide for Coronary Revascularization.血管内成像与生理评估与生物力学——哪种对冠状动脉血运重建是更好的指导？
Diagnostics (Basel). 2023 Jun 19;13(12):2117. doi: 10.3390/diagnostics13122117.
5
Natural products targeting inflammation-related metabolic disorders: A comprehensive review.针对炎症相关代谢紊乱的天然产物：综述
Heliyon. 2023 Jun 2;9(6):e16919. doi: 10.1016/j.heliyon.2023.e16919. eCollection 2023 Jun.
6
Prognostic role of tissue plasminogen activator in coronary artery disease with or without aortic valve sclerosis.组织型纤溶酶原激活物在合并或不合并主动脉瓣钙化的冠状动脉疾病中的预后作用。
ESC Heart Fail. 2023 Aug;10(4):2541-2549. doi: 10.1002/ehf2.14420. Epub 2023 Jun 12.
7
Vutiglabridin Modulates Paraoxonase 1 and Ameliorates Diet-Induced Obesity in Hyperlipidemic Mice.Vutiglabridin 调节对氧磷酶 1 并改善高脂血症小鼠的饮食诱导肥胖。
Biomolecules. 2023 Apr 18;13(4):687. doi: 10.3390/biom13040687.
8
Coronary artery properties in atherosclerosis: A deep learning predictive model.动脉粥样硬化中的冠状动脉特性：一种深度学习预测模型。
Front Physiol. 2023 Apr 5;14:1162436. doi: 10.3389/fphys.2023.1162436. eCollection 2023.
9
HMGB1, angel or devil, in ischemic stroke.HMGB1：在缺血性脑卒中里的天使还是魔鬼？
Brain Behav. 2023 May;13(5):e2987. doi: 10.1002/brb3.2987. Epub 2023 Apr 16.
10
Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease.血浆脂蛋白(a)和组织纤溶酶原激活物与动脉粥样硬化性心血管疾病风险增加相关。
Heliyon. 2022 Jun 30;8(7):e09836. doi: 10.1016/j.heliyon.2022.e09836. eCollection 2022 Jul.